Loading...
Loading...
- Henry Schein Inc HSIC raised its 2021 guidance after reporting first-quarter earnings, which topped the consensus.
- It posted an adjusted EPS of $1.24 ahead of the consensus of $0.85. Reported EPS came in at $1.16 compared to $0.91 a year ago.
- Net sales of $2.9 billion were well above the consensus of $2.8 billion, increased 20.4% Y/Y, and included 14.9% internal growth in local currencies, 3.3% growth from acquisitions, and 2.2% growth related to foreign currency exchange.
- Its medical segment registered global sales growth of 24% to $993 million, while its dental business’ revenues increased 21.3% to $1.8 billion.
- Guidance: Henry Schein raised its FY21 financial guidance, setting its projected adjusted EPS at $3.70 or above, versus analyst consensus of $3.72.
- Price Action: HSIC shares are up 6.20% at $78.60 during the market trading session on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in